Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (725)

« Back to Publications

Hypertrophic cardiomyopathy caused by Filamin-C (FLNC) variants has restrictive and extracardiac features and a distinctive ECG.

de Villiers C. et al, (2026), Heart Rhythm

Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathies.

Kramarenko D. et al, (2026)

Left Atrial Reservoir Strain Predicts Atrial Fibrillation in Hypertrophic Cardiomyopathy: Insights from the NHLBI HCM Registry.

Beyhoff N. et al, (2026), JACC Cardiovasc Imaging, 19, 133 - 135

Myocardial Entropy and Risk Predictors in Hypertrophic Cardiomyopathy: An Analysis From the NHLBI HCM Registry.

Antiochos P. et al, (2025), Circ Cardiovasc Imaging, 18

Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database.

Gudmundsson S. et al, (2025), Nat Commun, 16

Sex Differences in the Genetic Causes of Dilated Cardiomyopathy.

Mangino M. et al, (2025), J Am Coll Cardiol, 86, 400 - 403

icamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCM.

Saberi S. et al, (2025), JACC Heart Fail, 13

Regulatory T cells attenuate chronic inflammation and cardiac fibrosis in hypertrophic cardiomyopathy.

Wang Y-J. et al, (2025), Sci Transl Med, 17

Considerations for drug trials in hypertrophic cardiomyopathy.

Farrant JP. et al, (2025), ESC Heart Fail, 12, 1095 - 1112

n ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten.

Leinhos L. et al, (2025), Sci Rep, 15

Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settings.

Zheng SL. et al, (2025), Nat Genet, 57, 563 - 571

Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy.

Tadros R. et al, (2025), Nat Genet, 57, 530 - 538

Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk.

Ashkir Z. et al, (2025), Eur Heart J Cardiovasc Imaging, 26, 218 - 228

Multiparametric cardiovascular magnetic resonance evaluation of myocardial perfusion, oxygenation, and energetics in hypertrophic cardiomyopathy following cardiac myosin inhibitor therapy.

Finnigan LEM. et al, (2025), Eur Heart J Cardiovasc Imaging, 26

Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy.

Tahir UA. et al, (2024), Circ Heart Fail, 17

Load More

1
2
3
4
5
6
7
...
»